164 related articles for article (PubMed ID: 23956981)
1. Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome.
Fernandes-Cerqueira C; Sampaio-Maia B; Quelhas-Santos J; Moreira-Rodrigues M; Simões-Silva L; Blazquez-Medela AM; Martinez-Salgado C; Lopez-Novoa JM; Pestana M
Biomed Res Int; 2013; 2013():397391. PubMed ID: 23956981
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
3. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
Valentin JP; Qiu C; Muldowney WP; Ying WZ; Gardner DG; Humphreys MH
J Clin Invest; 1992 Oct; 90(4):1302-12. PubMed ID: 1328296
[TBL] [Abstract][Full Text] [Related]
4. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
Ni XP; Safai M; Gardner DG; Humphreys MH
Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
[TBL] [Abstract][Full Text] [Related]
5. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
Ni X; Cheng Y; Cao L; Gardner DG; Humphreys MH
J Am Soc Nephrol; 1996 Oct; 7(10):2110-8. PubMed ID: 8915970
[TBL] [Abstract][Full Text] [Related]
7. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.
Ni XP; Safai M; Rishi R; Baylis C; Humphreys MH
J Am Soc Nephrol; 2004 May; 15(5):1254-60. PubMed ID: 15100365
[TBL] [Abstract][Full Text] [Related]
8. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
9. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
[TBL] [Abstract][Full Text] [Related]
10. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
Plum J; Mirzaian Y; Grabensee B
Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
[TBL] [Abstract][Full Text] [Related]
12. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
Palluk R; Veress AT; Sonnenberg H
Pharmacology; 1989; 38(4):214-25. PubMed ID: 2526952
[TBL] [Abstract][Full Text] [Related]
13. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
14. The effect of atrial natriuretic peptide infusion on renal haemodynamics and plasma lipoproteins in puromycin aminonucleoside nephrosis in rats.
Radin MJ; McCune SA
Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):245-51. PubMed ID: 8485924
[TBL] [Abstract][Full Text] [Related]
15. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
16. Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion.
Kouyoumdzian NM; Rukavina Mikusic NL; Kravetz MC; Lee BM; Carranza A; Del Mauro JS; Pandolfo M; Gironacci MM; Gorzalczany S; Toblli JE; Fernández BE; Choi MR
PLoS One; 2016; 11(7):e0157487. PubMed ID: 27392042
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP.
Soares TJ; Coimbra TM; Martins AR; Pereira AG; Carnio EC; Branco LG; Albuquerque-Araujo WI; de Nucci G; Favaretto AL; Gutkowska J; McCann SM; Antunes-Rodrigues J
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):278-83. PubMed ID: 9874809
[TBL] [Abstract][Full Text] [Related]
18. Four-hour atrial natriuretic peptide infusion in conscious rats: effects on urinary volume, sodium, and cyclic GMP.
Campbell HT; Lightfoot BO; Sklar AH
Proc Soc Exp Biol Med; 1988 Dec; 189(3):317-24. PubMed ID: 2849771
[TBL] [Abstract][Full Text] [Related]
19. Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome.
Kikuchi M; Fujimoto S; Fukae H; Kinoshita H; Kita T; Nakazato M; Eto T
J Am Soc Nephrol; 2005 Feb; 16(2):392-7. PubMed ID: 15590761
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide in renal development.
Chevalier RL
Pediatr Nephrol; 1993 Oct; 7(5):652-6. PubMed ID: 8251341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
